A Phase 3 Research Study for People Living with Chronic Neutropenia (CN)
Learn More About the 4WARD Study
The goal of this study is to help the researchers learn if the oral investigative study medicine, mavorixafor, helps people with chronic neutropenia. See if you may qualify.
Learn about chronic neutropenia, rare diseases and clinical research. Find resources offering resources questions to ask your doctor, videos, toolkits and more.
You are now leaving the Chronic Neutropenia Study website and entering a website that is not owned or controlled by X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. makes no representation as to the accuracy of the information contained on websites we do not own or control. X4 Pharmaceuticals, Inc. does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.